SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
130.20    2.40 (1.88%)
Bid:
130.00
Ask:
130.40
Spread: 0.40 (0.308%)
Market Cap: £268.15m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Trading Update

11 Nov 2025 07:00

RNS Number : 9552G
Forterra plc
11 November 2025
 

11 November 2025

FORTERRA PLC

 

Full year guidance maintained

 

Forterra plc, "the Group" a leading UK manufacturer of essential clay and concrete building products, provides this trading update for the ten-month period ended 31 October 2025.

 

Summary

 

·

YTD revenue of £336m, 16% ahead of the prior year (£290m)

·

New build housing demand remains stronger than the depressed RMI market

·

H2 despatches and revenue expected to be at similar levels to H1

·

Full year guidance maintained; H2 adjusted EBITDA expected to be modestly ahead of the H1 figure

 

Current Trading

 

Tougher prior year comparatives along with a recent moderation of demand from the run rates seen around the middle of the year have resulted in year on year revenue growth over the last four months reducing to 10% relative to the 20.4% reported in H1. New build housing continues to be our strongest market segment with RM&I remaining depressed. Accordingly, we continue to benefit from our greater exposure to extruded or wire cut bricks over soft mud.

 

Department for Business and Trade figures show that domestic brick despatches for the nine-month period to September 2025 were 10% ahead of the 2024 comparative, with our own brick market share continuing to recover toward longer term norms. Brick imports remain subdued, and whilst ahead of the prior year, remain flat as a percentage of overall consumption.

 

We continue to actively manage our production capacity with demand varying significantly by product type. Production continues to ramp up as planned at Desford, with both kilns now operational, increasing our output of extruded bricks and ensuring we continue to meet customer demand following a significant destocking during 2025. Elsewhere, we expect to continue managing output as we retain our discipline in matching production to demand.

 

Our financial position continues to strengthen and we anticipate that year-end net debt before leases will be below H1, with leverage a little above one times adjusted EBITDA on a banking covenant basis.

 

Strategic Progress

 

Construction at our Wilnecote factory is nearing completion, with commissioning underway and the first bricks expected to be produced ahead of the year end. Wilnecote will offer an enhanced range of bricks for the premium commercial and specification market, increasing our exposure to this attractive segment.

 

We have also made good progress in designing and commissioning the initial range of brick slips from our innovative Accrington facility with the initial range due to be launched shortly.

 

The previously announced closures of our Bison Bespoke and Formpave operations have been executed in accordance with our plans.

 

Outlook

 

We anticipate that H2 despatches and revenues will be at similar levels to H1. Consistent with our previous guidance, H2 adjusted EBITDA is expected to be modestly ahead of the H1 figure.

 

Whilst we remain mindful of the continued economic uncertainty and the impact it is having on current demand, the medium-term market fundamentals remain attractive with a shortage of housing, a strong desire within government to address this, and a constrained supply of essential building products. The Board remains confident that our recent investments in new production capacity leave the Group well placed to benefit from a future recovery of our markets.

 

ENQUIRIES

 

Forterra plc +44 1604 707 600

Neil Ash, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

 

FTI Consulting +44 203 727 1340

Richard Mountain / Victoria Hayns

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBCBDBSGBDGUG
Date   Source Headline
11th Jun 20262:52 pmRNSGrant under Long Term Incentive Plan
11th Jun 20267:00 amRNSDirectorate change
9th Jun 202611:53 amRNSHolding(s) in Company
9th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20269:45 amRNSTransaction in Own Shares
2nd Jun 202612:32 pmRNSEmployee Benefit Trust Share Purchase
2nd Jun 202612:30 pmRNSTotal Voting Rights and Capital
1st Jun 20267:00 amRNSAppointment of New Independent NED
27th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:03 pmRNSHolding(s) in Company
19th May 20264:41 pmRNSAnnual General Meeting 2026 Results
19th May 20267:01 amRNSTransaction in Own Shares
19th May 20267:00 amRNSAGM Trading Update
12th May 20261:32 pmRNSTransaction in Own Shares
12th May 20267:00 amRNSAGM RESOLUTION – APPROVAL OF REMUNERATION POLICY
7th May 20261:43 pmRNSHolding(s) in Company
6th May 202610:50 amRNSTransaction in Own Shares
6th May 20269:58 amRNSTotal Voting Rights and Capital
6th May 20269:55 amRNSEmployee Benefit Trust Share Purchase
28th Apr 202610:20 amRNSHolding(s) in Company
28th Apr 202610:18 amRNSTransaction in Own Shares
21st Apr 202611:31 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSEmployee Benefit Trust Share Purchase
15th Apr 20265:40 pmRNSNotice of Annual General Meeting 2026
14th Apr 202610:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSAppointment of new Independent NED
9th Apr 202610:15 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSDirector Declaration
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20262:07 pmRNSTotal Voting Rights
7th Apr 202612:47 pmRNSEmployee Benefit Trust Share Purchase
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20261:03 pmRNSDirector / PCA Shareholdings
25th Mar 202610:50 amRNSAnnual Report and Accounts 2025
24th Mar 202610:40 amRNSTransaction in Own Shares
24th Mar 20269:01 amRNSHolding(s) in Company
24th Mar 20267:00 amRNSReplacement:Grant under Deferred Annual Bonus Plan
20th Mar 20268:45 amRNSGrant under Deferred Annual Bonus Plan
17th Mar 20267:00 amRNSEmployee Benefit Trust Share Purchase
17th Mar 20267:00 amRNSEmployee Benefit Trust Share Purchase
16th Mar 202610:32 amRNSLaunch of £20m Share Buyback Programme
16th Mar 202610:32 amRNSLaunch of £20m Share Buyback Programme
11th Mar 20267:00 amRNSFull Year Results
3rd Mar 20263:27 pmRNSEmployee Benefit Trust Share Purchase
18th Feb 20262:27 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202612:26 pmRNSEmployee Benefit Trust Share Purchase
29th Jan 20268:33 amRNSHolding(s) in Company
28th Jan 20269:21 amRNSHolding(s) in Company
26th Jan 20264:07 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSFull Year 2025 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.